Перевести на Переведено сервисом «Яндекс.Перевод»

Vanda Pharmaceuticals

Страна
USA
Краткое название
Vanda Pharmaceuticals
Штаб квартира
2200 Pennsylvania Avenue NW Suite 300E
Члены правления

Mihael H. Polymeropoulos, M.D.,
President and Chief Executive Officer (Bio)
James Kelly, CFA,
Sr. Vice President, Chief Financial Officer & Treasurer (Bio)
Robert Repella,
Sr. Vice President, Chief Commercial Officer (Bio)
Gunther Birznieks,
Vice President, Business Development (Bio)
Deepak Phadke, Ph.D.,
Vice President of Manufa
Vice President, Program Director (Bio)
Marlene Dressman, Ph.D.,
Sr. Director, Program Director (Bio)
Louis Licamele, Ph.D.,
Head of Informatics (Bio)

Стадия проекта
Производство
Заболевания
Шизофрения
Тикер
VNDA
Текущие владельцы

Howard Pien,
Director and Chairman of the Board (Bio)
Mihael H. Polymeropoulos, M.D.,
President and Chief Executive Officer (Bio)
Michael Cola,
Director (Bio)
Richard W. Dugan,
irector (Bio)
Steven Galson, M.D., M.P.H.,
Director (Bio)
Vincent J. Milano,
Director (Bio)
H. Thomas Watkins,
Director (Bio)

Объем фонда
560.9300
Технологии
Приборы, Сервисы, Технологии, Фармацевтика, Химия